Etiology and Epidemiology of Acute Lower Respiratory Infections Among Hospitalized Pediatric Patients in Northeastern China: A Retrospective Study from 2023 to 2025 Authors: Hang-Yu Zhao, Shi-Yao Zhang, Rui Wang, Xiu-Ying Zhang, Xue-Feng Wang Published: 2026 ABSTRACT AbstractPurposeTo analyze the etiological and epidemiological characteristics of acute lower respiratory infection (ALRI) in hospitalized children in Northeast China (Shenyang, Liaoning Province) following the lifting of non-pharmaceutical interventions (NPIs).Patients and MethodsClinical data and test results for 12 respiratory pathogens from 26,721 hospitalized children with ALRI admitted to two hospitals in Shenyang between January 2023 and December 2025 were retrospectively analyzed. Pathogen detection was performed using polymerase chain reaction (PCR) or serological methods. To control for diagnostic heterogeneity, analyses were stratified by PCR and serology as follows: chi-square test for age, gender, and seasonal distributions; multivariate logistic regression for independent factors associated with pathogen positivity; and Spearman’s rank correlation test for associations between meteorological factors and monthly positivity rates.ResultsPCR testing showed that rhinovirus (RV) had the highest positivity rate (13.80%), followed by influenza A virus (IAV) and respiratory syncytial virus (RSV). RSV was most common in infants aged <1 year, while RV and IAV were more common in children aged 3-<6 years. The positivity rate of RV was higher in males than in females (P < 0.001). IAV and RSV peaked in winter and spring, whereas RV peaked in summer. Serological testing showed that Mycoplasma pneumoniae (MP) had the highest positivity rate (37.64%), followed by RSV and adenovirus (ADV). The detection peaks of MP and ADV were concentrated in children aged 6–14 years. The positivity rates of Epstein-Barr virus (EBV), MP, and Chlamydia pneumoniae (Cpn) were lower in males than in females (all P < 0.05). MP peaked in autumn and winter, while IAV peaked in winter. The age and seasonal distribution patterns of RSV were consistent with those from PCR testing. Age, season, and gender were independent influencing factors for pathogen infection. Meteorological factors were significantly correlated with monthly positivity rates of specific pathogens (P < 0.05).ConclusionFollowing the lifting of NPIs, the pathogen spectrum of childhood ALRI in Shenyang presented distinct seasonal, age, and gender differences. Age, season, and gender were independent influencing factors for pathogen infection. Although methodological differences exist between PCR and serological testing, comparisons within the same detection method are generally reliable.Keywords: acute lower respiratory infection, children, respiratory pathogens, co-infection, epidemiology Introduction Acute lower respiratory infection (ALRI) is the most common infectious disease in children and the leading cause of death among children under five years of age worldwide, posing a serious threat to child health and exacerbating family and societal burdens. Following the outbreak of coronavirus disease 2019 (COVID-19) in 2020, non-pharmaceutical interventions (NPIs) implemented in China effectively controlled the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while also significantly suppressing the circulation of common pathogens such as influenza A virus (IAV), Mycoplasma pneumoniae (MP), and respiratory syncytial virus (RSV).1–4 After the adjustment of epidemic prevention and control policies at the end of 2022, NPIs were gradually lifted, and the aforementioned pathogens showed a clear “rebound” trend.5–9 However, the long-term impact of NPIs on the current epidemiological patterns of respiratory infections remains unclear,10 and the ongoing circulation of SARS-CoV-2 further complicates prevention and control efforts. Therefore, elucidating the evolving epidemiological patterns of respiratory pathogens is of great significance for optimizing vaccination strategies and improving public health prevention and control systems. In the post-pandemic era, epidemiological surveys conducted in multiple regions of China have revealed significant age- and season-related differences in the circulation of respiratory pathogens. A study in Xiantao City found that pathogens were detected in 99.3% of children with acute respiratory tract infection, of whom 88.7% had multiple infections, with distinct age and seasonal variations in pathogen distribution.11 In contrast, a study in Hanzhong City indicated that although co-infections exist in children with acute respiratory tract infection, single pathogen infections remain predominant, and the distribution of pathogens differs significantly across age groups.12 These findings suggest that the infection patterns and epidemiological characteristics of respiratory pathogens in children may vary considerably across different regions. Against this backdrop, Mycoplasma pneumoniae (MP), as an important pathogen of community-acquired pneumonia in children, has been confirmed by multiple studies to have become the most common non-bacterial pathogen in acute respiratory tract infections among children in most regions during the post-pandemic era.13–17 Shenyang is located in the southern part of Northeast China, in the central region of Liaoning Province (41°48′N, 123°25′E), at an average elevation of approximately 50 meters, and has a temperate, semi-humid continental climate. The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine and the Liaoning Children’s Hospital are the major pediatric diagnosis and treatment centers in Shenyang, serving a population of over 9 million permanent residents covering Shenyang and surrounding cities. Studies conducted during the early and containment phases of the pandemic have preliminarily revealed the epidemiological characteristics of respiratory pathogens in children in Shenyang. Between 2019 and 2022, acute respiratory tract infections in children in this region were predominantly caused by single virus infections, with respiratory syncytial virus (RSV) and human parainfluenza virus (HPIV) being the main pathogens, and winter being the peak season for incidence.18 A study from November 2021 to October 2022 further showed that the major pathogens were influenza B virus (IBV), RSV, rhinovirus (RV), IAV, and human metapneumovirus (HMPV), with distinct seasonal peaks: IBV circulated in winter, RSV in winter and spring, while RV and IAV peaked in summer-autumn and summer, respectively.19 However, the data collection periods of the above studies mainly covered the phase of strict implementation of NPIs, and there is currently a lack of post-pandemic pathogen circulation data for this region. Following the adjustment of prevention and control policies at the end of 2022, along with the lifting of NPIs and the ongoing circulation of SARS-CoV-2, the pathogen circulation spectrum, seasonal characteristics, and co-infection patterns of childhood ALRI in Shenyang have likely undergone complex changes, presenting new features distinct from those observed before the pandemic and during the containment period. To address this gap, the present study retrospectively collected and analyzed demographic and etiological data from 26,721 hospitalizations of children with ALRI admitted to two hospitals in Shenyang between January 2023 and December 2025. This study aims to describe the positivity rates of respiratory pathogens and their monthly distribution patterns, analyze the circulation patterns of major pathogens across different age groups, sexes, and seasons, explore independent influencing factors for respiratory pathogen infection, evaluate the impact of meteorological factors on monthly pathogen positivity rates, and further analyze co-infection patterns, with the goal of providing evidence for the prevention and control of childhood ALRI in Shenyang and in areas with similar climatic conditions. Materials and Methods Research Population This retrospective study was conducted based on electronic medical records from Liaoning Children’s Hospital (Hospital A) and the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (Hospital B) in Liaoning Province, China. As the study aimed to comprehensively include all eligible cases within the specified period, no sample size calculation or power analysis was performed. Medical data were collected from January 1, 2023, to December 31, 2025, and all hospitalized patients meeting the clinical diagnosis of ALRI routinely underwent respiratory pathogen testing. The inclusion criteria were as follows: a) age 0 to 14 years; b) diagnosis of ALRI according to the diagnostic criteria for acute lower respiratory tract infection in Zhu Futang Practical Pediatrics,20 with clinical manifestations of lower respiratory tract infection such as bronchitis, pneumonia, or bronchopneumonia (diagnosed by a physician at attending level or above); c) underwent respiratory pathogen testing. The exclusion criteria were as follows: a) neonates (born <28 days); b) confirmed COVID-19 cases; c) readmission for the same illness within two weeks (only the first admission was included); d) patients with incomplete clinical data or missing pathogen test results; e) concurrent immunodeficiency diseases or congenital airway malformations. Data Collection Based on electronic medical records, we reviewed the medical records of hospitalized patients to assess eligibility according to the inclusion criteria and collected clinical information including sex, age, admission date, diagnosis, and length of hospital stay. Laboratory test results were obtained from the hospital information system (HIS). The unit of analysis was each hospitalization episode (each hospital admission was counted as an independent record). To ensure statistical independence and avoid bias introduced by repeated measurements, only the test results of respiratory specimens collected on the day of admission or the following morning during a single hospitalization were collected for each patient. Meteorological data were obtained from the official monitoring records of the Shenyang National Surface Meteorological Station provided by the China Meteorological Administration (https://www.cma.gov.cn/). The dataset included monthly mean atmospheric pressure (hPa), monthly mean temperature (°C), monthly mean relative humidity (%), and monthly mean wind speed (m/s) during the period from January 2023 to December 2025. These publicly available datasets require no special authorization for research use. Sample Collection and Etiological Testing Different laboratory tests were performed for pediatric patients with ALRI based on clinical needs. Nucleic acid testing was conducted only at Hospital A. Oropharyngeal swab samples were collected from patients on the day of admission and tested using the StepOnePlus™ Real-Time PCR System (Applied Biosystems, USA) for the following pathogens: IAV, IBV, RSV, adenovirus (ADV), herpes simplex virus (HSV), HPIV, RV, human bocavirus (HBoV), and human metapneumovirus (hMPV). For serological testing, venous blood samples were collected on the day of admission or the following morning. After centrifugation, serum was separated, and pathogen-specific IgM antibodies were detected using a fully automated chemiluminescence immunoassay analyzer. At Hospital A, the iFlash 3000 fully automated chemiluminescence immunoassay analyzer (Shenzhen Yhlo Biotech Co., Ltd., Shenzhen, China) and its proprietary magnetic particle chemiluminescence kits were used to detect IgM antibodies against Epstein-Barr virus (EBV), Mycoplasma pneumoniae (MP), and Chlamydia pneumoniae (Cpn). At Hospital B, the MAGLUMI X3 fully automated chemiluminescence immunoassay analyzer (Shenzhen New Industries Biomedical Engineering Co., Ltd., Shenzhen, China) and its proprietary kit were used to detect EBV viral capsid antigen IgM antibody; the AutoLumo A2000 Plus-M2 fully automated chemiluminescence immunoassay analyzer (Autobio Diagnostics Co., Ltd., Zhengzhou, China) and its proprietary magnetic particle chemiluminescence kits were used to detect IgM antibodies against MP, Cpn, IAV, IBV, RSV, ADV, and HSV. Co-infection was defined as the detection of two or more distinct pathogens during a single hospitalization. Since serological testing (IgM) cannot reliably distinguish between recent infection and past exposure, co-infection analyses were restricted to PCR-based results. All positive results were obtained from routine clinical laboratory testing, strictly following the manufacturers’ instructions and standard operating procedures. No additional confirmatory testing was performed for co-infection results. Statistical Analysis Statistical analyses were performed using SPSS 27.0 (IBM Corp., Armonk, NY, USA). Categorical data were presented as frequencies (n) and percentages (%). Normality was assessed using the Shapiro–Wilk test. Normally distributed continuous data were expressed as mean ± standard deviation, and comparisons between two groups were performed using the independent samples t-test. Non-normally distributed continuous data were expressed as median (interquartile range), and comparisons between two groups were performed using the Mann–Whitney U-test. To control for diagnostic method heterogeneity, analyses were stratified by PCR and serology as follows: the chi-square (χ2) test compared age, gender, and seasonal distributions of each pathogen. Multivariate logistic regression analysis was performed to adjust for potential confounding factors (including age, gender, season, and diagnosis) to identify independent factors associated with positivity for individual pathogens. The correlations between monthly pathogen positivity rates and meteorological factors were analyzed using Spearman’s rank correlation test. GraphPad Prism 10.1.2 (GraphPad Software, Boston, MA, USA) was used for graphing. Co-infection patterns were visualized as UpSet plots using the online data visualization platform ChiPlot (https://www.chiplot.online/). A P-value < 0.05 was considered statistically significant for all tests. Results General Clinical Characteristics of Patients Between January 2023 and December 2025, a total of 27,636 hospitalizations of children under 14 years of age with ALRI were initially screened. After exclusions, 26,721 hospitalizations were finally included in the analysis (Figure S1). Among the included hospitalizations, 19,123 tested positive for at least one pathogen, yielding an overall positivity rate of 71.57%. The median age was 57 months (IQR: 38–89). Of these, 14,666 were male, with a median age of 56 months (IQR: 37–88), and 12,055 were female, with a median age of 58 months (IQR: 39–90). The difference in overall pathogen positivity rate between sexes was statistically significant (P = 0.021), with females having a higher positivity rate (72.27%) than males (70.99%). The difference in pathogen positivity across the four age groups was statistically significant (P < 0.001), with the highest positivity rate in the 6–14 years group (75.45%). The difference in pathogen positivity across seasons was statistically significant (P < 0.001), with the highest positivity rate in autumn (76.45%), followed by winter (75.08%), and the lowest in spring (61.50%). A significant difference in pathogen positivity was also observed across diagnostic categories (P < 0.001), with children diagnosed with severe pneumonia having the highest positivity rate (82.04%) (Table 1). Table 1Baseline characteristics of the study population and subgroup-specific pathogen positivity ratesCharacteristicsTotal (n=26721)Positive (n=19123)Negative (n=7598)χ2/ZDfPnn (%)*nGender5.33910.021 Male1466610,411(70.99%)4255 Female120558712(72.27%)3343Age group146.6133<0.001 <1 year1322842(63.69%)480 1–<3 years45033181(70.64%)1322 3–<6 years107117415(69.23%)3296 6–14 years101857685(75.45%)2500Season458.7623<0.001 Spring (3.4.5)46602866(61.50%)1794 Summer (6.7.8)52093463(66.48%)1746 Autumn (9.10.11)10,3807935(76.45%)2445 Winter (12.1.2)64724859(75.08%)1613Diagnosis Pneumonia2030515,244 (75.08%)5061606.0474<0.001 Acute bronchitis59713536 (59.22%)2435 Severe pneumonia362297 (82.04%)65 Acute laryngotracheitis6734 (50.75%)33 Acute bronchiolitis1612 (75.00%)4 Median (IQR) length of stay (days)7(5, 8)7(6, 8)6(5, 7)−31.452–<0.001Abbreviation: ARTI, Acute respiratory tract infection. *Positivity rate was calculated as (number of positive cases / total cases in that subgroup) × 100%. Baseline characteristics of the study population and subgroup-specific pathogen positivity rates Abbreviation: ARTI, Acute respiratory tract infection. *Positivity rate was calculated as (number of positive cases / total cases in that subgroup) × 100%. Monthly Distribution Characteristics of Pathogens The positivity rates of respiratory pathogens showed that, at the PCR detection level, RV had the highest positivity rate (13.80%), followed by IAV (11.93%) and RSV (11.39%). At the serological detection level, MP had the highest positivity rate (37.64%), followed by RSV (5.41%) and ADV (3.73%) (Figure 1A). Monthly distribution of pathogens. (A) Overall positivity rates of pathogens. (B) Positivity rates of each pathogen from 2023 to 2025; the three points a, b, and c within the dashed box represent the positivity rates in 2023, 2024, and 2025, respectively. ***P < 0.001, **P < 0.01, *P < 0.05. (C) Monthly detection trends of each pathogen from January 2023 to December 2025. (data are the same as in Figure 1B). Abbreviations: Jan, January; Apr, April; Jul, July; Oct, October; IAV, Influenza A virus; IBV, Influenza B virus; RSV, Respiratory syncytial virus; ADV, Adenovirus; HSV, Herpes simplex virus; EBV, Epstein-Barr virus; MP, Mycoplasma pneumoniae; Cpn, Chlamydia pneumoniae; HPIV, Human parainfluenza virus; RV, Rhinovirus; HBoV, Human bocavirus; hMPV, Human metapneumovirus. PCR testing showed that the positivity rates of IAV, IBV, RSV, ADV, HSV, HPIV, HBoV, and hMPV differed significantly across years (all P < 0.05), whereas RV showed no significant difference (P = 0.179) (Figure 1B). IAV peaked in March 2023 (246 hospitalizations, 52.01%), December 2024 (322 hospitalizations, 23.49%), and November 2025 (786 hospitalizations, 60.09%). RSV peaked in May 2023 (274 hospitalizations, 34.82%), February 2024 (137 hospitalizations, 27.96%), and September 2025 (174 hospitalizations, 27.44%). ADV reached its highest peak in December 2023 (296 hospitalizations, 26.79%), with a smaller peak in November 2024 (170 hospitalizations, 14.36%) (Figure 1C). Serological testing showed that the positivity rates of IAV, RSV, ADV, EBV, MP, and Cpn differed significantly across years (all P < 0.05), whereas HSV showed no significant difference (P = 0.454) (Figure 1B). MP peaked between September 2023 and January 2024, with the highest peak in October 2023 (1083 hospitalizations, 72.98%), followed by a sharp decline and low-to-moderate circulation throughout 2024, with only a small peak in September–October 2024 (Figures 1C). Age Distribution Characteristics of Pathogens PCR testing showed that the positivity rates of IAV, IBV, RSV, ADV, HPIV, RV, HBoV, and hMPV differed significantly across age groups (all P < 0.001). Among these, RSV and hMPV peaked in the <1 year group. HBoV peaked in the 1–<3 years group. IAV, IBV, ADV, and RV peaked in the 3–<6 years group. HPIV was concentrated in children under 6 years of age (Figure 2A and Table S1). Pathogen positivity by age group. (A) Positivity rates of each pathogen in different age groups; the four points a, b, c, and d within the dashed box represent the positivity rates in the <1 year, 1–<3 years, 3–<6 years, and 6–14 years age groups, respectively. ****P < 0.0001, ***P < 0.001, **P < 0.01. (B) Distribution of pathogen detection across ages from 0 to 14 years (data are the same as in Figure 2A). Abbreviations: IAV, Influenza A virus; IBV, Influenza B virus; RSV, Respiratory syncytial virus; ADV, Adenovirus; HSV, Herpes simplex virus; EBV, Epstein-Barr virus; MP, Mycoplasma pneumoniae; Cpn, Chlamydia pneumoniae; HPIV, Human parainfluenza virus; RV, Rhinovirus; HBoV, Human bocavirus; hMPV, Human metapneumovirus. Serological testing showed that the positivity rates of IAV, RSV, ADV, HSV, EBV, and Cpn also differed significantly across age groups (all P < 0.001), with MP showing the most significant difference (P < 0.0001). Specifically, IAV peaked in the <1 year and 6–14 years groups. RSV peaked in the <1 year group. HSV peaked in the 1–<3 years and 6–14 years groups. EBV was concentrated in children aged 3–14 years. ADV, MP, and Cpn peaked in the 6–14 years group (Figure 2A and Table S1). Figure 2B illustrates the distribution characteristics of pathogens across different age groups. PCR testing showed that the positivity rates of IAV, IBV, and HSV remained relatively stable across age groups. The positivity rates of HPIV, RSV, and hMPV decreased with increasing age. ADV, RV, and HBoV showed a unimodal distribution, first increasing and then decreasing with age. Serological testing showed that the positivity rates of EBV, MP, and Cpn increased with age. IAV and ADV remained relatively, while RSV decreased with age. IBV showed a trend of first decreasing, then increasing, and then decreasing again. HSV exhibited a bimodal pattern. Gender Distribution Characteristics of Pathogens PCR testing showed that only RV showed a significant gender difference, with a higher positivity rate in male children than in female children (P < 0.001). Serological testing showed that only EBV, MP, and Cpn showed significant gender differences, with higher positivity rates in female children than in male children (all P < 0.05) (Figure S2 and Table S2). Seasonal Distribution Characteristics of Pathogens PCR testing showed that the positivity rates of IAV, IBV, RSV, ADV, HPIV, RV, HBoV, and hMPV differed significantly across seasons (all P < 0.001) (Figure 3A). IBV and RSV showed typical winter-spring predominance; IAV and ADV had higher detection rates in winter; HPIV and RV peaked mainly in summer and were lower in winter; HBoV was higher in summer and autumn but lower in winter and spring; hMPV was higher in autumn; and HSV exhibited sporadic year-round distribution without a single-season peak (Figure 3B and Table S3). Season-specific detection of pathogens. (A) Positivity rates of each pathogen from spring to winter; the four points a, b, c, and d within the dashed box represent the positivity rates in spring, summer, autumn, and winter, respectively. ***P < 0.001, *P < 0.05. (B) Seasonal positivity rates of each pathogen; Q2, Q3, Q4, and Q1 represent spring, summer, autumn, and winter, respectively. Abbreviations: IAV, Influenza A virus; IBV, Influenza B virus; RSV, Respiratory syncytial virus; ADV, Adenovirus; HSV, Herpes simplex virus; EBV, Epstein-Barr virus; MP, Mycoplasma pneumoniae; Cpn, Chlamydia pneumoniae; HPIV, Human parainfluenza virus; RV, Rhinovirus; HBoV, Human bocavirus; hMPV, Human metapneumovirus. Serological testing showed that the positivity rates of IAV and MP (all P < 0.001), as well as IBV, RSV, and Cpn (all P < 0.05), showed significant seasonal differences (Figure 3A). IAV peaked in winter, IBV in spring, RSV was higher in winter and spring, and MP and Cpn both peaked in autumn and winter with lower rates in spring and summer (Figure 3B and Table S3). Analysis of Factors Influencing Respiratory Pathogen Infection PCR testing showed that male children had a higher risk of ADV (AOR = 1.113) and RV (AOR = 1.135) infection than female children (all P < 0.05). Using children aged 6–14 years as the reference group, the risk of RSV and HPIV infection increased significantly with decreasing age (all P < 0.001). The risk of IAV and IBV infection was reduced only in children aged <1 year (AOR = 0.435–0.608, all P < 0.01). For RV, the infection risk was reduced in children aged <1 year (AOR = 0.712, P < 0.001) but increased in children aged 3-<6 years (AOR = 1.177, P < 0.001). ADV infection risk was reduced in children aged <3 years (AOR = 0.454–0.756, P < 0.001). HBoV infection risk was increased in children aged 1-<6 years (AOR = 1.454–1.935, P < 0.001). hMPV infection risk was increased across all age groups (all P < 0.001). Using winter as the reference group, the risks of IAV, IBV, RSV, and ADV were reduced in the other three seasons (AOR = 0.186–0.793, all P < 0.001). HBoV and hMPV risks were increased only in autumn (AOR = 1.837–2.015, all P < 0.001) and decreased in spring and summer. RV risk was increased in all three seasons (AOR = 1.356–2.016, all P < 0.001), with a progressive increase from spring to autumn. HPIV risk was increased in summer (AOR = 2.326, P < 0.001) and autumn (AOR = 2.311, P < 0.001) but decreased in spring (AOR = 0.808, P = 0.023). Compared with children with pneumonia, those with acute bronchitis had increased risks of IAV, ADV, HSV, HPIV, RV, HBoV, and hMPV (AOR = 1.220–2.969, all P < 0.001) but a decreased risk of RSV (AOR = 0.412, P < 0.001). Children with severe pneumonia had a higher risk of RV infection than those with mild pneumonia (AOR = 2.724, P < 0.001), whereas the risks of IAV, IBV, ADV, and hMPV were reduced (AOR = 0.220–0.628, all P < 0.05). Children with acute laryngotracheitis had a reduced risk of RSV infection (AOR = 0.321, P = 0.029). Acute bronchiolitis was associated only with an increased risk of RV infection (AOR = 3.677, P = 0.028) (Tables S4 and S6). Serological testing showed that male children had a lower risk of MP (AOR = 0.850) and EBV (AOR = 0.777) infection than female children (all P < 0.001). Using children aged 6–14 years as the reference group, the risk of MP and Cpn infection decreased with decreasing age (all P < 0.001), whereas the risk of RSV infection increased with decreasing age (all P < 0.001). The risk of EBV infection was reduced only in children aged <3 years (AOR = 0.137–0.709, P < 0.01). The risks of IBV and HSV were reduced only in children aged 3-<6 years (AOR = 0.390–0.407, P < 0.05). Using winter as the reference group, the risks of IAV and RSV were significantly reduced in the other three seasons (AOR = 0.325–0.684, all P < 0.05). Unlike the PCR results, IBV risk was increased only in spring (AOR = 6.090, P = 0.012), and ADV risk was reduced only in spring and autumn (AOR = 0.441–0.680, all P < 0.05). MP risk was increased only in autumn (AOR = 1.353, P < 0.001) and decreased in spring and summer. HSV risk was increased only in spring (AOR = 2.746, P = 0.003). Cpn risk was lower in autumn than in winter (AOR = 0.797, P = 0.038). Compared with children with pneumonia, those with acute bronchitis had reduced risks of MP and Cpn detection (AOR = 0.381–0.763, all P < 0.05), whereas the increased risk of ADV detection was consistent with the PCR results (AOR = 1.437, P = 0.038). Children with acute laryngotracheitis had a lower risk of MP detection than those with pneumonia (AOR = 0.392, P = 0.008) (Tables S5 and S6). Influence of Meteorological Factors on Monthly Pathogen Positivity Rates PCR testing showed that monthly mean atmospheric pressure was moderately positively correlated with IAV (r = 0.4941) and IBV (r = 0.4146) (all P < 0.05), and strongly negatively correlated with HPIV (r = −0.7324) and RV (r = −0.7203) (all P < 0.001). Monthly mean temperature was moderately negatively correlated with IAV (r = −0.571) and IBV (r = −0.5276) (all P < 0.001), and strongly positively correlated with HPIV (r = 0.7251) and RV (r = 0.7511) (all P < 0.0001). Monthly mean relative humidity was moderately negatively correlated with IAV (r = −0.5261) and IBV (r = −0.5053) (all P < 0.01), and positively correlated with HPIV (r = 0.5434), HBoV (r = 0.4283), and RV (r = 0.3524) (all P < 0.05). Monthly mean wind speed was moderately positively correlated with IBV (r = 0.4054, P = 0.0142), and negatively correlated with HPIV (r = −0.3394) and HBoV (r = −0.5206) (all P < 0.05). Serological testing showed that only monthly mean relative humidity was significantly correlated with MP (r = 0.4142, P = 0.012), whereas no significant correlations were observed between other meteorological factors and pathogen positivity rates (all P > 0.05) (Figure 4). Correlation analysis between pathogen positivity rates and meteorological factors. Abbreviations: IAV, Influenza A virus; IBV, Influenza B virus; MP, Mycoplasma pneumoniae; HPIV, Human parainfluenza virus; RV, Rhinovirus; HBoV. Overall, as monthly mean atmospheric pressure increased, the infection rates of IAV and IBV increased, while those of HPIV and RV decreased. As monthly mean temperature increased, the infection rates of IAV and IBV decreased, whereas those of HPIV and RV increased. As monthly mean relative humidity increased, the infection rates of IAV and IBV decreased, while those of HPIV, MP, RV, and HBoV increased. As monthly mean wind speed increased, the infection rate of IBV increased, whereas those of HPIV and HBoV decreased (Figures S3-S6 and Table S7). Analysis of Co-Infection and Its Influencing Factors Among 22,616 hospitalizations, 1467 (6.49%) were identified as co-infections. Double infection was the predominant co-infection pattern (1342 hospitalizations, 5.93%), followed by triple infection (119 hospitalizations, 0.53%) and quadruple infection (6 hospitalizations, 0.03%) (Figure 5A). Figure 5B illustrates the monthly dynamics of co-infection hospitalizations from January 2023 to December 2025. Co-infections exhibited significant seasonal fluctuations, with hospitalization peaks occurring each winter (November–December). The most common co-infection combination was RSV + RV, followed by ADV + RV and IAV + RV (Figure 5C). Co-infection patterns of pathogens. (A) Bar chart showing the positivity rates of pathogen co-infections. (B) Trends in monthly co-infection hospitalizations from January 2023 to December 2025. (C) UpSet plot illustrating the distribution of co-infection combinations among different respiratory pathogens. Abbreviations: IAV, Influenza A virus; IBV, Influenza B virus; RSV, Respiratory syncytial virus; ADV, Adenovirus; HSV, Herpes simplex virus; EBV, Epstein-Barr virus; MP, Mycoplasma pneumoniae; Cpn, Chlamydia pneumoniae; HPIV, Human parainfluenza virus; RV, Rhinovirus; HBoV, Human bocavirus; hMPV, Human metapneumovirus. Discussion Based on data from two hospitals in Shenyang from 2023 to 2025, this study analyzed the epidemiological characteristics of 12 respiratory pathogens in hospitalized children with ALRI following the lifting of NPIs. The results showed an overall pathogen positivity rate of 71.57%, which was higher than that reported in Inner Mongolia (58.55%)14 but lower than that in Luoding (74.6%),21 and similar to that in Northeast Sichuan (73.66%).22 These differences may be attributed to variations in regional climate, study year, detection methods, and the rebound effect of pathogens after the lifting of NPIs. PCR testing showed that RV had the highest positivity rate, followed by IAV and RSV. Serological testing showed that MP had the highest positivity rate, followed by RSV and ADV. These pathogens constituted the major pathogens in the study area, which is consistent with findings from Yichun.23 The positivity rate of MP in this study was higher than that reported in Xuzhou (20.74%)17 and Inner Mongolia (19.16%),14 but lower than that in Shijiazhuang (39.48%).15 From a temporal perspective, the circulation of respiratory pathogens in hospitalized children with ALRI in Shenyang over the past three years exhibited phased fluctuation characteristics. MP reached its highest peak during the study period in October 2023, consistent with the concurrent epidemic trend in Shenzhen,7 suggesting that 2023 may have been a pandemic year for MP. This may be attributed to reduced population immunity resulting from prolonged low-level exposure to pathogens, thereby increasing susceptibility to MP. The age susceptibility to different pathogens varied. PCR testing showed that the positivity rates of HPIV, RSV, and hMPV decreased with age. Among these, RSV24–26 and hMPV peaked in the <1 year group, which may be attributed to immature airway development and incomplete immune function in infants and young children. HPIV was concentrated in children under 6 years of age.27,28 The positivity rates of ADV, RV, and HBoV first increased and then decreased with age. HBoV peaked in the 1–<3 years group,29 whereas IAV, IBV,27 ADV,26,30,31 and RV peaked in the 3–<6 years group, suggesting that increased exposure due to group living after nursery enrollment is the main reason for the higher susceptibility to these pathogens in this age group. Serological testing showed that the positivity rates of EBV, MP, and Cpn increased with age. Among these, MP peaked in school-aged children aged 6–14 years,32–34 which may be associated with cluster transmission in school settings. MP is primarily transmitted via respiratory droplets. After entering kindergartens and schools, preschool and school-aged children may have increased opportunities for pathogen exposure due to group living, which is associated with an elevated risk of infection. The trend of RSV positivity rate was consistent with that of PCR testing. In contrast to PCR testing, the peak of ADV detection by serological methods was concentrated in school-aged children aged 6–14 years. This discrepancy may be attributed to the different stages of infection reflected by the two detection methods. In addition to age, gender was also an important factor influencing pathogen distribution. PCR testing showed that only RV had a higher detection rate in male children than in female children.35–37 Serological testing showed that EBV, MP,32–35,38 and Cpn had higher detection rates in female children than in male children, consistent with previous studies. These differences may be attributed to the fact that boys engage in more outdoor activities and have relatively poorer hand hygiene habits, which may increase the risk of exposure to and transmission of non-enveloped viruses such as RV. In contrast, girls tend to prefer indoor close-contact social activities, which may facilitate the spread of pathogens transmitted via respiratory droplets or close contact, such as MP, EBV, and Cpn. PCR testing showed that IBV39 and RSV were predominantly prevalent in winter and spring. IBV was associated with high atmospheric pressure, low temperature, and low humidity, conditions that may enhance viral stability in aerosols and promote indoor transmission. IAV and ADV14,40 was more common in winter, which may be associated with increased indoor activities and poor air circulation. HPIV and RV peaked mainly in summer,28,41,42 which may be attributed to low atmospheric pressure, high temperature, and high humidity, as warm and humid environments may favor viral survival on surfaces and facilitate contact transmission. HBoV showed higher detection rates in summer and autumn and lower rates in winter and spring, a seasonal pattern that may be associated with high humidity and high wind speed. hMPV had a higher detection rate in autumn, which may be related to increased child clustering following the school start season. Serological testing showed that MP and Cpn were predominantly prevalent in autumn and winter. The autumn-winter predominance of MP is consistent with previous studies;32,33,43–46 however, its positive correlation with relative humidity is inconsistent with actual seasonal characteristics, suggesting that factors such as population contact patterns may play more important roles. IAV peaked in winter, IBV in spring, and RSV was higher in winter and spring, with seasonal distribution trends similar to those observed in PCR testing. Multivariate logistic regression analysis showed that age, season, diagnosis, and gender were independent influencing factors for respiratory pathogen infection. PCR testing revealed that male children had a higher risk of ADV and RV infection than female children, which may be attributed to relatively delayed immune development in males. The high risk of RSV, HPIV, and hMPV infection in young children may be related to immature airway development, waning maternal antibodies, and incomplete immune function in infants and toddlers. IAV, IBV, RSV, and ADV had the highest infection risk in winter, which may be associated with enhanced viral stability in aerosols under cold and dry conditions and increased indoor crowding during winter. hMPV, RV, and HBoV had the highest infection risk in autumn, while HPIV showed a significantly elevated risk in summer and autumn, possibly due to prolonged viral survival in warm and humid environments and increased child aggregation activities during summer. Compared with children with pneumonia, those with acute bronchitis had a higher risk of IAV, RV, ADV, HSV, HPIV, HBoV, and hMPV infection, but a lower risk of RSV infection. This may be related to the site preference of different pathogens in the respiratory tract, suggesting that RSV is more likely to cause pulmonary inflammatory disease. Children with severe pneumonia had a higher risk of RV infection than those with mild pneumonia, indicating that clinicians should pay attention to the potential pathogenic role of RV in severe cases. Acute bronchiolitis was associated only with an increased risk of RV infection, suggesting that RV may have become an important pathogen of acute bronchiolitis in the post-pandemic era. Serological testing showed that male children had a lower risk of MP and EBV infection than female children. In vitro studies have confirmed that estrogen enhances the adhesion of MP to the respiratory epithelium,47 providing a possible mechanistic explanation for the higher susceptibility of female children to MP. The consistent gender differences in respiratory pathogen infections across different detection methods further support gender as an important independent risk factor for respiratory pathogen infections in children. The high risk of MP and Cpn infection in school-aged children aged 6–14 years suggests that close contact within school settings may be a key factor in the transmission of these pathogens. The age- and season-related risk trends for RSV, as well as the seasonal risk trend for IAV, were generally consistent with the PCR results. Seasonal differences in IBV and ADV between the two detection methods may arise because PCR reflects acute current infection whereas IgM serology represents recent new infection, with different detection windows and infection recognition periods, leading to incomplete concordance in seasonal epidemic characteristics between the two methods. Consistent with PCR findings, acute bronchitis was associated with an increased risk of ADV detection, whereas the risks of MP and Cpn detection were reduced, further suggesting that MP and Cpn are more likely to cause pulmonary inflammatory disease. Analysis of co-infection patterns revealed complex interactions among respiratory pathogens. In this study, co-infection was observed in 6.49% of hospitalizations, predominantly as dual infections (5.93%). The most common co-infection combination was RSV + RV,36,48,49 indicating potential synergistic effects or shared transmission routes among pathogens. After the lifting of NPIs, the disease burden of co-infections remained persistently high and exhibited a stable winter-predominant pattern, suggesting that winter may be a critical window for the synergistic transmission of multiple pathogens. Clinically, screening and comprehensive management of co-infections should be strengthened in winter to avoid underestimating disease complexity due to single-pathogen testing. The present study has the following limitations. First, there may be heterogeneity in detection methods. Although analyses were stratified according to the different detection methods used for different pathogens (PCR vs. serology), direct comparisons of positivity rates across pathogens may still be subject to bias due to differences in sensitivity and detection windows between the two methods, and should therefore be interpreted with caution. Second, clinical outcome indicators (such as oxygen therapy use, antibiotic use, imaging findings, and inflammatory markers) were not collected, precluding assessment of the association between pathogen infection and disease severity. Third, the study covered only two hospitals in Shenyang, with a limited sample source, and caution should be exercised when extrapolating the findings to other regions or populations. This study confirms that, following the lifting of NPIs, the pathogen spectrum of childhood ALRI in Shenyang presented distinct seasonal, age, and gender differences. Age, season, and gender were independent influencing factors for pathogen infection. Comparisons within the same detection method (PCR or serology) are reliable; however, further validation using unified diagnostic methods is warranted. Acknowledgments We sincerely thank Professor Chen Ci from Liaoning Children’s Hospital, as well as our colleagues from the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, for their valuable contributions to this study. Funding Statement No funding was received for this study. Data Sharing Statement Condensed anonymized data are available from the corresponding author on reasonable request. Ethics Statements This study was approved by the Ethics Committee of The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (Approval No.: 2021065ND(KT)-044-08). Due to the retrospective design and anonymization of patient data, the requirement for written informed consent was waived in accordance with institutional and national regulations. The study complied with the ethical standards of the Declaration of Helsinki. Author Contributions All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure The authors report no conflicts of interest in this work. References Associated Data Data Availability Statement Condensed anonymized data are available from the corresponding author on reasonable request.